Immunophenotyping and Flow Cytometric Analysis of Cellular Populations in Translational Research Studies
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institutes of Health (NIH) Office of the Director, specifically the Office of Logistics and Operations, plans to award a non-competitive contract to Becton, Dickinson and Company's BD Biosciences Business Unit for immunophenotyping and flow cytometric analysis services to support translational research studies. This contract, classified under NAICS code 334516, is intended to provide reliable access to flow cytometry instrumentation essential for the analysis of cellular populations within the intramural research activities of the National Institute of Diabetes and Digestive and Kidney Diseases. The contract will be awarded without full and open competition under FAR Part 13-Simplified Acquisition Procedures, with a simplified acquisition threshold not exceeding $350,000. The requirement stems from the need for timely and routine sample acquisition and analysis to complement ongoing laboratory workflows that currently rely on shared flow cytometry resources across multiple research groups. The solicitation invites interested parties to submit capability statements, technical and cost proposals, and necessary identification and certification documents by June 22, 2026. While this presolicitation notice does not constitute a competitive request, responses will be reviewed to determine if a competitive process should be initiated or if the government will proceed with a sole-source award. All submissions must be electronically sent to the designated contracting officer by the specified deadline, and respondents must be registered in the System for Award Management (SAM).
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
General Information
Document Type:
Presolicitation
Synopsis Number:
75N98026Q00589
Posted Date:
June 10, 2026
Original Response Date:
June 22, 2026
Current Response Date:
June 22, 2026
Set Aside:
N/A
NAICS Code:
334516
Contracting Office Address
National Institutes of Health (NIH), Office of the Director (OD)
Office of Logistics and Operations (OLAO)
Office of Acquisition and Logistics Management (OALM)
Hospital and Laboratory Support Division
6701 Rockledge Drive
Bethesda, MD 20817
Description
INTRODUCTION
THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to:
Becton, Dickinson and Company
BD Biosciences Business Unit
One Becton Drive
Franklin Lakes, NJ 07417
NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE
The intended procurement is classified under NAICS code 334516 with a Size Standard $1000.
REGULATORY AUTHORITY
The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01, March 13, 2026. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000).
STATUTORY AUTHORITY
This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
GENERAL INFORMATION
- Title: Immunophenotyping and Flow Cytometric Analysis of Cellular Populations in Translational Research Studies
- Background Information: The National Institute of Diabetes and Digestive and Kidney Diseases conducts intramural research that requires immunophenotyping and analysis of cellular populations using flow cytometry. These activities are performed across multiple projects within the laboratory and require reliable access to instrumentation capable of supporting routine and time-sensitive experimental workflows. Current laboratory operations utilize shared flow cytometry resources for sample acquisition and analysis. These systems support a broad user base and are scheduled across multiple research groups. To support ongoing laboratory activities, access to a flow cytometry system within the laboratory is required to perform sample acquisition and analysis in alignment with experimental workflows..
CLOSING STATEMENT
This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.
A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.
All responses must be received by June 22, 2026 at 9:00 AM Eastern time and must reference solicitation number 75N98026Q00589. Responses may be submitted electronically to Mr. James Law, Contracting Officer at James.Law@nih.gov. Fax responses will not be accepted.
"All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.”